We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+11.71%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$461B
AUM Growth
+$24.9B
Cap. Flow
-$12.1B
Cap. Flow %
-2.62%
Top 10 Hldgs %
40.03%
Holding
5,800
New
615
Increased
1,596
Reduced
2,751
Closed
340

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$2.34B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.65B
3
TSLA icon
Tesla
TSLA
+$1.45B
4
QQQ icon
Invesco QQQ Trust
QQQ
+$1.01B
5
AAPL icon
Apple
AAPL
+$833M

Sector Composition

Rank Sector Weight
1 Technology 20.48%
2 Financials 7.27%
3 Consumer Discretionary 6.82%
4 Communication Services 5.06%
5 Healthcare 4.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FBLG icon
5326
FibroBiologics
FBLG
$3.98M
0
SMXT icon
5327
Solarmax Technology
SMXT
$20.5M
$1 ﹤0.01%
1
BTOC
5328
Armlogi Holding Corp
BTOC
$10.9M
$1 ﹤0.01%
1
-1
-50% -$1
EMO.RT
5329
DELISTED
ClearBridge Energy Midstream Opportunity Fund Rights expiring Oct 10 2025
EMO.RT
$1 ﹤0.01%
+35
New +$3
AES icon
5330
CALL
AES
AES
$10.6B
-80,000
Closed -$842K
AFMD
5331
DELISTED
Affimed
AFMD
-863
Closed -$66
AGNC icon
5332
PUT
AGNC Investment
AGNC
$12.7B
-2,500,000
Closed -$23M
AGS
5333
DELISTED
PlayAGS
AGS
-4,083
Closed -$51K
AKYA
5334
DELISTED
Akoya BioSciences
AKYA
-1,412
Closed -$1.84K
ALB icon
5335
CALL
Albemarle
ALB
$13.4B
-300,000
Closed -$18.8M
ALGM icon
5336
PUT
Allegro MicroSystems
ALGM
$7.86B
-1,767,200
Closed -$60.4M
ALGN icon
5337
PUT
Align Technology
ALGN
$12.9B
-6,000
Closed -$1.14M
ALKS icon
5338
CALL
Alkermes
ALKS
$8.11B
-75,000
Closed -$2.15M
ALKS icon
5339
PUT
Alkermes
ALKS
$8.11B
-100
Closed -$2.86K
AMED
5340
DELISTED
Amedisys
AMED
-14,221
Closed -$1.4M
AMKR icon
5341
PUT
Amkor Technology
AMKR
$10.6B
-900,000
Closed -$18.9M
ANSS
5342
DELISTED
Ansys
ANSS
-302,706
Closed -$106M
APD icon
5343
CALL
Air Products & Chemicals
APD
$65.5B
-275,000
Closed -$77.6M
ARCC icon
5344
CALL
Ares Capital
ARCC
$13.4B
-125,000
Closed -$2.75M
ARCC icon
5345
PUT
Ares Capital
ARCC
$13.4B
-125,000
Closed -$2.75M
ARES icon
5346
PUT
Ares Management
ARES
$28.1B
-10,500
Closed -$1.82M
ARKK icon
5347
CALL
ARK Innovation ETF
ARKK
$5.59B
-71,900
Closed -$5.05M
ARQT icon
5348
CALL
Arcutis Biotherapeutics
ARQT
$3.48B
-111,500
Closed -$1.56M
ASR icon
5349
Grupo Aeroportuario del Sureste
ASR
$8.16B
-3,029
Closed -$966K
ATOS icon
5350
Atossa Therapeutics
ATOS
$23M
-1,251
Closed -$15.6K

Similar funds

Barclays's Q3 2025 Portfolio in Review

As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
  • Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
  • Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
  • Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
  • Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
  • Barclays opened 615 new positions and closed 340 in Q3 2025.
  • Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.

Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.